ANXA2 and cancer: Fructose-bisphosphate aldolase A (aldolase A), peptidyl-prolyl cis-trans isomerase A (also known as cyclophilin A), and annexin A2 were upregulated in cancer regions (Table 3) and consequently selected as candidate diagnostic biomarkers.